Mateo Porres-Aguilar
Texas Tech University Health Sciences Center at El Paso
Internal medicineRadiologySurgeryPathologyCardiologyIntensive care medicinePediatricsPulmonary embolismPortopulmonary hypertensionHepatopulmonary syndromePortal hypertensionDiseaseMEDLINEThrombolysisLiver transplantationPulmonary hypertensionVenous thromboembolism2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)In patientMedicine
67Publications
9H-index
300Citations
Publications 66
Newest
#1Mateo Porres-Aguilar (Texas Tech University Health Sciences Center at El Paso)H-Index: 9
Last. Silvio A. Ñamendys-SilvaH-Index: 15
view all 4 authors...
Source
#1Mateo Porres-Aguilar (Texas Tech University Health Sciences Center at El Paso)H-Index: 9
#2Debabrata Mukherjee (Texas Tech University Health Sciences Center at El Paso)H-Index: 78
Source
#1Raphael Le Mao (French Institute of Health and Medical Research)H-Index: 1
#1Raphael Le Mao (French Institute of Health and Medical Research)H-Index: 5
Last. Manuel Monreal (Universidad Católica San Antonio de Murcia)H-Index: 75
view all 10 authors...
Background In patients with pulmonary embolism (PE), there is a lack of comprehensive data on the prevalence and prognostic significance of pre-existing obstructive sleep apnea (OSA). Methods In this study of patients with PE from the Registro Informatizado de la Enfermedad TromboEmbolica (RIETE) registry, we assessed the prevalence of OSA, and the association between pre-existing OSA and the outcomes of all-cause mortality, PE-related mortality, recurrences, and major bleeding over 30 days afte...
Source
#1Mateo Porres-Aguilar (Texas Tech University Health Sciences Center at El Paso)H-Index: 9
#2Victor F. Tapson (Cedars-Sinai Medical Center)H-Index: 94
Last. Debabrata Mukherjee (Texas Tech University Health Sciences Center at El Paso)H-Index: 78
view all 9 authors...
Venous thromboembolism associated with COVID-19, particularly acute pulmonary embolism, may represent a challenging and complex clinical scenario. The benefits of having a multidisciplinary pulmonary embolism response team (PERT) can be important during such a pandemic. The aim of PERT in the care of such patients is to provide fast, appropriate, multidisciplinary, team-based approach, with the common goal to tailor the best therapeutic decision making, prioritizing always optimal patient care, ...
1 CitationsSource
#1Mateo Porres-Aguilar (TTUHSC: Texas Tech University Health Sciences Center)H-Index: 9
#2Alejandro Lazo-Langner (UWO: University of Western Ontario)H-Index: 24
Last. Misael Uribe (UNAM: National Autonomous University of Mexico)H-Index: 1
view all 4 authors...
Source
Source
#1Mateo Porres-Aguilar (Texas Tech University Health Sciences Center at El Paso)H-Index: 9
#2Marius M. Hoeper (MHH: Hannover Medical School)H-Index: 99
Last. Victor F. Tapson (Cedars-Sinai Medical Center)H-Index: 94
view all 6 authors...
Chronic thromboembolic pulmonary hypertension (CTEPH) represents the later stage consequence of at least one or more unresolved episodes of acute pulmonary embolism; thus, indefinite anticoagulation is strongly recommended by current practice guidelines. Historically, vitamin K antagonists have been widely used in these patients. However, recent data indicate a shift toward direct oral anticoagulants (DOACs), despite lack of data on the safety and efficacy in this patient population. Herein, we ...
Source
#2Oscar C. MunozH-Index: 3
Last. Debabrata Mukherjee (Texas Tech University Health Sciences Center at El Paso)H-Index: 78
view all 4 authors...
The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus (SARS- CoV-2) is our latest pandemic and has turned out to be a global public health crisis. One of the special characteristics of this disease is that it may predispose patients to thrombotic disease both in the venous and arterial circulation. We review arterial and venous thromboembolic complications in patients with COVID-19, epidemiology, pathogenesis, hematologic biomarkers, and current antithro...
1 CitationsSource
Last. Moises AuronH-Index: 3
view all 3 authors...
Source
#1Mateo Porres-Aguilar (McGill University)H-Index: 9
#1Mateo Porres-Aguilar (McGill University)H-Index: 2
Last. Raúl Carrillo-EsperH-Index: 10
view all 9 authors...
La enfermedad grave por coronavirus 2019 (COVID-19) esta causada por el Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) y predispone a complicaciones tromboticas. En esta revision se aborda de manera practica la estrecha relacion entre la tromboembolia venosa y la COVID-19, enfatizando aspectos epidemiologicos, factores de riesgo y tromboprofilaxis, asi como potenciales opciones de anticoagulacion. Actualmente la evidencia cientifica es muy escasa, pero dia a dia seguimos aprendiend...
2 CitationsSource